Učitavanje...
A review of moxifloxacin for the treatment of drug-susceptible tuberculosis
Moxifloxacin, an 8-methoxy quinolone, is an important drug in the treatment of multidrug-resistant tuberculosis (MDR TB) and is being investigated in novel drug regimens with pretomanid, bedaquiline and pyrazinamide, or rifapentine, for the treatment of drug-susceptible tuberculosis. Early results o...
Spremljeno u:
| Izdano u: | J Clin Pharmacol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5663285/ https://ncbi.nlm.nih.gov/pubmed/28741299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.968 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|